Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Excelent
AddedFeb 15, 2024
UpdatedJun 18, 2026
Excelent

Excelent

Series A

Medical device firm specializing in minimally invasive solutions for rhinosinusitis treatment.

HQ
Durham, NC, US
Founded
2022
Overview
Compare
Fundraising
Employees

Excelent is a medical device company dedicated to partnering with Ear, Nose, and Throat surgeons to provide advanced technologies for the education and treatment of patients with rhinosinusitis. The firm specializes in minimally invasive solutions, aiming to improve patient outcomes and enhance the quality of care in the ENT field.

Excelent has made significant strides in the medical device industry, contributing to the advancement of minimally invasive treatments for rhinosinusitis. Their innovative products have positively impacted patient care, earning recognition within the medical community.

Excelent - Similar Companies

Aerin Medical logo

Aerin Medical

Dalent Medical logo

Dalent Medical

dalentmedical.com

Xact Medical logo

Xact Medical

xactmedical.com

XII Medical logo

XII Medical

xiimedical.com

Huxley Medical logo

Huxley Medical

huxleymed.com

Max Endoscopy logo

Max Endoscopy

maxendoscopy.com

Preceptis Medical logo

Preceptis Medical

Zelegent logo

Zelegent

zelegent.com

VenX logo

VenX

Invent Medical logo

Invent Medical

XN Health logo

XN Health

xn-health.com

Intact Medical logo

Intact Medical

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Exos logo

Exos

Endoclear logo

Endoclear

Excelent - Quick Facts

Who are Excelent's competitors?

Companies similar to Excelent include Aerin Medical, Dalent Medical, Xact Medical and XII Medical.

When was Excelent founded?

Excelent was founded in 2022.

Where is Excelent's headquarters located?

Excelent's headquarters is located in Durham, NC, US.

When was Excelent's last funding round?

Excelent's most recent funding round was for $6M (USD) in October 2022.

How much has Excelent raised to-date?

As of Oct 31, 2022, Excelent has raised a total of $6M (USD).

How many employees does Excelent have?

Excelent has 30 employees as of Feb 4, 2024.

Excelent - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified